162 related articles for article (PubMed ID: 25132576)
1. Associations between salivary alpha-amylase and catecholamines--a multilevel modeling approach.
Ditzen B; Ehlert U; Nater UM
Biol Psychol; 2014 Dec; 103():15-8. PubMed ID: 25132576
[TBL] [Abstract][Full Text] [Related]
2. Salivary alpha-amylase levels after yohimbine challenge in healthy men.
Ehlert U; Erni K; Hebisch G; Nater U
J Clin Endocrinol Metab; 2006 Dec; 91(12):5130-3. PubMed ID: 16968802
[TBL] [Abstract][Full Text] [Related]
3. Acute stress responses in salivary alpha-amylase predict increases of plasma norepinephrine.
Thoma MV; Kirschbaum C; Wolf JM; Rohleder N
Biol Psychol; 2012 Dec; 91(3):342-8. PubMed ID: 22954623
[TBL] [Abstract][Full Text] [Related]
4. Norepinephrine infusion with and without alpha-adrenergic blockade by phentolamine increases salivary alpha amylase in healthy men.
Kuebler U; von Känel R; Heimgartner N; Zuccarella-Hackl C; Stirnimann G; Ehlert U; Wirtz PH
Psychoneuroendocrinology; 2014 Nov; 49():290-8. PubMed ID: 25128931
[TBL] [Abstract][Full Text] [Related]
5. Psychological stress-induced changes in salivary alpha-amylase and adrenergic activity.
Kang Y
Nurs Health Sci; 2010 Dec; 12(4):477-84. PubMed ID: 21210927
[TBL] [Abstract][Full Text] [Related]
6. Alpha-Amylase Activity in Blood Increases after Pharmacological, But Not Psychological, Activation of the Adrenergic System.
Nater UM; La Marca R; Erni K; Ehlert U
PLoS One; 2015; 10(6):e0130449. PubMed ID: 26110636
[TBL] [Abstract][Full Text] [Related]
7. Representational similarity analysis offers a preview of the noradrenergic modulation of long-term fear memory at the time of encoding.
Visser RM; Kunze AE; Westhoff B; Scholte HS; Kindt M
Psychoneuroendocrinology; 2015 May; 55():8-20. PubMed ID: 25705798
[TBL] [Abstract][Full Text] [Related]
8. Norepinephrine transporter blocker atomoxetine increases salivary alpha amylase.
Warren CM; van den Brink RL; Nieuwenhuis S; Bosch JA
Psychoneuroendocrinology; 2017 Apr; 78():233-236. PubMed ID: 28232237
[TBL] [Abstract][Full Text] [Related]
9. Psychosocial Stress Increases Salivary Alpha-Amylase Activity Independently from Plasma Noradrenaline Levels.
Petrakova L; Doering BK; Vits S; Engler H; Rief W; Schedlowski M; Grigoleit JS
PLoS One; 2015; 10(8):e0134561. PubMed ID: 26247781
[TBL] [Abstract][Full Text] [Related]
10. Stress-induced changes in human salivary alpha-amylase activity -- associations with adrenergic activity.
Nater UM; La Marca R; Florin L; Moses A; Langhans W; Koller MM; Ehlert U
Psychoneuroendocrinology; 2006 Jan; 31(1):49-58. PubMed ID: 16002223
[TBL] [Abstract][Full Text] [Related]
11. Salivary α-amylase response to endotoxin administration in humans.
Grigoleit JS; Kullmann JS; Oberbeck R; Schedlowski M; Engler H
Psychoneuroendocrinology; 2013 Sep; 38(9):1819-23. PubMed ID: 23394872
[TBL] [Abstract][Full Text] [Related]
12. Does yohimbine hydrochloride facilitate fear extinction in virtual reality treatment of fear of flying? A randomized placebo-controlled trial.
Meyerbroeker K; Powers MB; van Stegeren A; Emmelkamp PM
Psychother Psychosom; 2012; 81(1):29-37. PubMed ID: 22116378
[TBL] [Abstract][Full Text] [Related]
13. Effects of methamphetamine on the noradrenergic activity biomarker salivary alpha-amylase.
Haile CN; De La Garza R; Mahoney JJ; Newton TF
Drug Alcohol Depend; 2013 Dec; 133(2):759-62. PubMed ID: 23968815
[TBL] [Abstract][Full Text] [Related]
14. Salivary alpha-amylase and noradrenaline responses to corticotropin-releasing hormone administration in humans.
Petrakova L; Boy K; Mittmann L; Möller L; Engler H; Schedlowski M
Biol Psychol; 2017 Jul; 127():34-39. PubMed ID: 28472693
[TBL] [Abstract][Full Text] [Related]
15. Psychosocial stress-induced activation of salivary alpha-amylase: an indicator of sympathetic activity?
Rohleder N; Nater UM; Wolf JM; Ehlert U; Kirschbaum C
Ann N Y Acad Sci; 2004 Dec; 1032():258-63. PubMed ID: 15677423
[TBL] [Abstract][Full Text] [Related]
16. High salivary alpha-amylase levels in patients with schizophrenia: A pilot study.
Inagaki T; Miyaoka T; Okazaki S; Yasuda H; Kawamukai T; Utani E; Wake R; Hayashida M; Horiguchi J; Tsuji S
Prog Neuropsychopharmacol Biol Psychiatry; 2010 May; 34(4):688-91. PubMed ID: 20347911
[TBL] [Abstract][Full Text] [Related]
17. No response of plasma substance P, but delayed increase of interleukin-1 receptor antagonist to acute psychosocial stress.
Rohleder N; Wolf JM; Herpfer I; Fiebich BL; Kirschbaum C; Lieb K
Life Sci; 2006 May; 78(26):3082-9. PubMed ID: 16414081
[TBL] [Abstract][Full Text] [Related]
18. Salivary alpha amylase as marker for adrenergic activity during stress: effect of betablockade.
van Stegeren A; Rohleder N; Everaerd W; Wolf OT
Psychoneuroendocrinology; 2006 Jan; 31(1):137-41. PubMed ID: 16046076
[TBL] [Abstract][Full Text] [Related]
19. Effects of yohimbine on human sympathetic nervous system function.
Murburg MM; Villacres EC; Ko GN; Veith RC
J Clin Endocrinol Metab; 1991 Oct; 73(4):861-5. PubMed ID: 1890156
[TBL] [Abstract][Full Text] [Related]
20. Psychosocial determinants of diurnal alpha-amylase among healthy Quebec workers.
Marchand A; Juster RP; Lupien SJ; Durand P
Psychoneuroendocrinology; 2016 Apr; 66():65-74. PubMed ID: 26799849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
